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 Mouse models have become a major focus 
of diabetic nephropathy research during 
the past decade. 1,2 A major reason for this 
emphasis has been the ease of genetic 
manipulation in the mouse to either 
enhance or interrupt the abnormal signal-
ing and pathologic lesions of diabetic 
nephropathy. Th is increasing reliance on 
the mouse has occurred even in the face of 
the nearly impenetrable resistance to 
nephropathy of the C57BL / 6 mouse, 1,2 the 
workhorse of genetic murine research. 
Most studies of nephropathy in mice have 
focused on candidate pathways and single-
gene manipulation to test the eff ects of 
those pathways on diabetic changes, but 
recently several studies have used less 
direct and more open-ended approaches 
to gain insight into diabetic kidney disease. 
Th ese include more systemic approaches 
in which candidate pathways are not inter-
rogated but in which all associations with 
the ultimate nephropathy phenotype are 
sought. One such example is illuminated 
in the report by Chua  et al. 3 (this issue). 
 Th is elegantly comprehensive study 
used well-established gene mapping 
methods with an overlay of genome-
wide expression analysis. These tools 
have been critical for analysis of non-
mendelian diseases in humans for which 
there are complex genetic susceptibili-
ties, such as type 1 and type 2 diabetes, 
diabetic nephropathy itself, 4 – 6 and other 
forms of chronic kidney disease. Such 
studies, including genome-wide associa-
tion studies and other similarly broad 
genetic approaches, have identifi ed genes 
and gene loci associated with nephropa-
thy in humans that lie outside the usual 
pantheon of pathways known to be dis-
rupted in chronic kidney disease. Indeed, 
there has been an explosion of reports in 
the past two years that have identifi ed 
new nephropathy genes in humans with 
the use of these techniques. Perhaps the 
most dramatic of these are the identifi ca-
tion of uromodulin, 7 the gene encoding 
Tamm-Horsfall protein, and the identi-
fication of  MYH9 , 8,9 a non-muscle 
myosin gene, as major susceptibility loci 
for progression of chronic kidney dis-
ease. Indeed, variants of MYH9 may 
explain up to 70 % of nondiabetic forms 
of end-stage renal disease in African 
Americans. 8 – 10 Ironically, one of the 
reports identifying this locus of nondia-
betic kidney disease was from the Family 
Investigation of Nephropathy and 
 Diabetes (FIND) Research Group. 8 Th e 
FIND group has yet to fi nd such a pow-
erful locus for diabetic nephropathy sus-
ceptibility as MYH9 is for nondiabetic 
disease, although a recent report identi-
fi ed several suggestive diabetic neph-
ropathy loci. 4 Nonetheless, it is certain 
that these approaches have directed our 
attention to genes and gene products 
that had hitherto been ignored as pos-
sible major participants in progression 
of kidney disease. Th us, these reports 
have already charted new fi elds of study 
and are likely to lead rapidly to a diag-
nostic reclassifi cation and perhaps novel 
approaches to therapy for many patients 
with chronic kidney disease. 
 As Chua and associates 3 correctly 
argue, the pursuit of similar studies in 
mice can complement these pathfi nding 
analyses in humans by taking advantage 
of the genetic and environmental uni-
formity of mice and the easy availability 
of relevant tissues from these models. 
Another advantage, perhaps too obvious 
to be noted by the authors, is that 
genome-wide susceptibility mapping, 
including genome-wide expression anal-
ysis (which has not yet been completed by 
the investigators), is orders of magnitude 
less expensive and time-consuming than 
similar studies in humans. Th e fi ndings 
of Chua  et al. 3 were completed by a single 
research group, whereas the human 
genome-wide association studies have 
involved well-funded multicenter consor-
tia at work for the better part of a decade. 
Of course, the mouse studies, even though 
relatively parsimonious, might be 
regarded as profl igate were they not to 
identify genes that are relevant to human 
progressive nephropathy. 
 So how did Chua  et al. 3 do in that 
regard? Although the jury is still out, it 
seems relatively likely that they have hit 
on an important locus for nephropathy. 
Th eir strategy was well reasoned. Avoid-
ing the trap of the nephropathy-resistant 
C57BL / 6 mouse by turning it into a per-
fect negative control, the investigators 
used the db / db type 2 diabetic nephropa-
thy model on a relatively nephropathic 
genetic background, the FVB mouse 
(more on that later). They analyzed 
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 linkage of the clinical nephropathy pheno-
type to genetic loci identifi ed by single-
nucleotide polymorphisms in the diabetic 
progeny of FVB and C57BL / 6 mice ( Fig-
ure 1 ). In contrast to the expected identi-
fi cation of a number of relatively small 
genetic contributors to nephropathy, the 
investigators found a single FVB locus on 
chromosome 8 that remarkably accounted 
for a major amount of the histopathologic 
diff erences between mice. Importantly, 
there was no association between this 
locus and non-nephropathy phenotypes 
such as the degree of hyperglycemia. Th e 
authors are currently investigating genes 
in the region to identify the nephropathy 
gene. Th en they and other investigators 
will be able to ascertain whether the para-
log of this gene is also involved in human 
nephropathy. 
 Although promising, there are some 
reasons to be concerned that the chromo-
some 8 gene may not be directly relevant 
to human diabetic nephropathy. Part of 
this concern has to do with the peculiar 
issues of mouse nephropathy. As has 
already been noted, the C57BL / 6 mouse 
is particularly resistant to all types of 
 kidney disease (at some point those pro-
tective loci need to be identified). The 
FVB diabetic mouse develops more sig-
nifi cant nephropathy than the C57BL / 6 
mouse, but nephropathy has been variable 
in this strain 1 and therefore appears to be 
subject to environmental eff ects that could 
make any genetic susceptibility locus less 
 applicable to human disease. Moreover, 
this strain and virtually all mouse strains 
develop only early glomerulopathy and do 
not develop substantial tubulointerstitial 
fi brosis or a progressive decline in glomer-
ular fi ltration rate, so the chromosome 8 
gene may be important only for such early 
changes. 1,2 In addition, the diabetic FVB 
mice in this study developed a sudden 
increase in albuminuria between 21 and 
24 weeks of age, the acuity of which is 
atypical of human diabetic nephropathy. 
None of this is to deny that the authors 
have identified an important murine 
nephropathy locus that will likely teach us 
quite a bit about the development of albu-
minuria and glomerulosclerosis; it just 
may not instruct us as much about human 
diabetic nephropathy,  per se . 
 Indeed, there is a two-way street 
between such mouse and human studies. 
Traffi  c in both directions can aid in eluci-
dating the fundamental processes of dia-
betic nephropathy and other chronic 
kidney diseases. Besides determining 
whether nephropathy loci in mice are 
present in humans with disease, neph-
ropathy genes and gene products identi-
fi ed in human studies can be placed in 
susceptible murine strains, such as db / db 
FVB or diabetic DBA / 2 mice, 1 and the 
eff ects on nephropathy can be determined. 
In addition, interactions between mouse 
and human nephropathy genes can be 
interrogated in murine studies. Finally, 
putatively critical gene expression changes 
in human kidney diseases can be validated 
in mouse models. This interspecies 
exchange freeway should eventually help 
us truly understand, treat, and prevent 
diabetic nephropathy. 
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 Figure 1  |  Resistant C57BL / 6 (B6) mice were backcrossed with nephropathic FVB / N (FVB) mice to produce diabetic progeny (diabetic F 1 ), 
which were analyzed for histopathologic features of nephropathy and genotyped for over 100 single-nucleotide polymorphisms. A single 
locus on chromosome 8 showed a major linkage to the combined nephropathy histology score, suggesting a major contribution of this single gene to 
the development of nephropathy in FVB diabetic mice. 
